-
If you purchased shares of Exar Corporation (NYSE:EXAR) and currently hold any of those NYSE:EXAR shares, you have certain options and you should contact the Shareholders Foundation, Inc.
-
To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Investigation Overview
April 3, 2017 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Exar Corporation (NYSE:EXAR), was announced concerning whether the takeover of Exar Corporation by MaxLinear, Inc is unfair to NYSE:EXAR stockholders.
The investigation by a law firm concerns whether certain officers and directors of Exar Corporation breached their fiduciary duties owed to NYSE:EXAR investors in connection with the proposed acquisition.
On March 29, 2017, MaxLinear, Inc. (NYSE: MXL) and Exar Corporation (NYSE: EXAR) announced that they have entered into an agreement under which MaxLinear has agreed to acquire Exar for $13.00 per share in cash.
However, given that at least one analyst has set the high target price for NYSE:EXAR shares at $14.00 per share, the investigation concerns whether the offer is unfair to NYSE:EXAR stockholders. More specifically, the investigation concerns whether the Exar Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.
